Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter related infections in children with cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Arora, Ramandeep S ^a   Roberts, Rebecca ^b   Eden, Tim O B ^c   Pizer, Barry ^d  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CHLORHEXIDINE; MINOCYCLINE; PLATINUM; POLITEF; RIFAMPICIN; SILVER; SULFADIAZINE SILVER;

ANTIMICROBIAL THERAPY; ANTISEPSIS; BACTEREMIA; CANCER PATIENT; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VEIN; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; ERYTHEMA; FOLLOW UP; FUNGEMIA; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; POCKET INFECTION; REVIEW; SENSITIVITY ANALYSIS; SKIN DECONTAMINATION; SKIN INDURATION; SKIN NECROSIS; SUBCLAVIAN VEIN CATHETER; TUNNEL INFECTION;

EID: 70349162077     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007785     Document Type: Review

References (12)

1. Akl EA, Karmath G, Yosuico V, Kim SY, Barba M, Sperati F, et al.Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheter. Cochrane Database of Systematic Reviews 2007, Issue 3. [Art. No.: CD006468. DOI: 10.1002/14651858.CD006468.pub2] (Pubitemid 351805433)
2. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. Morbidity and Mortality Weekly Report 2002;51:1-26.
3. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clinical Infectious Diseases 2001;33:1567-1572
4. Eggimann P, Sax H, Pittet D. Catheter-related infections. Microbes and Infection 2004;6:1033-1042
5. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org. The Cochrane Collaboration.
6. Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. American Journal of Pediatric Hematology Oncology 1991;13:130-136
7. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, et al.Epic2: national evidence-based guidelines for preventing healthcare- associated infections in NHS hospitals in England. Journal of Hospital Infection 2007;65S:S1-S64.
8. Raad I, Costerton W, Sabharwal U, SacilowskiM, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. Journal of Infectious Diseases 1993;168:400-407 (Pubitemid 23210618)
9. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. Journal of Infectious Diseases 1993;167:487-490
10. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infection Control and Hospital Epidemiology 2000;21:592-596 (Pubitemid 30735171)
11. Simon A, Bode U, Beutel K. Diagnosis and treatment of catheterrelated infections in paediatric oncology: an update. Clinical Microbiology and Infection 2006;12:606-620 (Pubitemid 43842480)
12. van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database of Systematic Reviews 2007, Issue 1. [Art. No.: CD003295. DOI: 10.1002/14651858.CD003295.pub2]